| 000 | 01587 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514230306.0 | ||
| 264 | 0 | _c20050809 | |
| 008 | 200508s 0 0 eng d | ||
| 022 | _a0959-8049 | ||
| 024 | 7 |
_a10.1016/j.ejca.2005.02.012 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPostma, T J | |
| 245 | 0 | 0 |
_aThe development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20. _h[electronic resource] |
| 260 |
_bEuropean journal of cancer (Oxford, England : 1990) _cMay 2005 |
||
| 300 |
_a1135-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPeripheral Nervous System Diseases _xchemically induced |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 |
_aSurveys and Questionnaires _xstandards |
| 700 | 1 | _aAaronson, N K | |
| 700 | 1 | _aHeimans, J J | |
| 700 | 1 | _aMuller, M J | |
| 700 | 1 | _aHildebrand, J G | |
| 700 | 1 | _aDelattre, J Y | |
| 700 | 1 | _aHoang-Xuan, K | |
| 700 | 1 | _aLantéri-Minet, M | |
| 700 | 1 | _aGrant, R | |
| 700 | 1 | _aHuddart, R | |
| 700 | 1 | _aMoynihan, C | |
| 700 | 1 | _aMaher, J | |
| 700 | 1 | _aLucey, R | |
| 773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 41 _gno. 8 _gp. 1135-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejca.2005.02.012 _zAvailable from publisher's website |
| 999 |
_c15573018 _d15573018 |
||